Absorption, Distribution, Metabolism, and Elimination of the Direct Renin Inhibitor Aliskiren in Healthy Volunteers-Reference-Cited by-同舟云学术

Absorption, Distribution, Metabolism, and Elimination of the Direct Renin Inhibitor Aliskiren in Healthy Volunteers

Published:2007-05-17 Issue:8 Volume:35 Page:1418-1428
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Waldmeier Felix,Glaenzel Ulrike,Wirz Bernard,Oberer Lukas,Schmid Dietmar,Seiberling Michael,Valencia Jessica,Riviere Gilles-Jacques,End Peter,Vaidyanathan Sujata

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference29 articles.

1. Combined Blockade of the Renin-Angiotensin System With Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Type 1 Receptor Antagonists

2. Renin inhibition with aliskiren: where are we now, and where are we going?

3. Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A computer-generated plan to develop an intelligent biosensor for investigation of the inhibition of renin by aliskiren: A journey from inhibition to biosensing;Sensing and Bio-Sensing Research;2024-08

2. Microneedles and Their Application in Transdermal Delivery of Antihypertensive Drugs—A Review;Pharmaceutics;2023-07-27

3. Nanoparticle approaches for the renin-angiotensin system;Heliyon;2023-06

4. Renin–angiotensin–aldosterone pathway modulators in chronic kidney disease: A comparative review;Frontiers in Pharmacology;2023-02-13

5. Aliskiren Hemifumarate Proliposomes for Improved Oral Drug Delivery: Formulation Development, In Vitro and In Vivo Permeability Testing;Molecules;2022-07-28